USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
04 Oct 2022 | 02:45 PM GMT

What are the Best Business Models for DTx in the US

Anchored by:

Kal Patel, MD
CEO and Co-Founder
BRIGHTINSIGHT

Participants:

Kal Patel, MD CEO and Co-FounderBrightInsight
Kal Patel, MD
CEO and Co-FounderBrightInsight
Chandana Fitzgerald President, CommunityHLTH
Chandana Fitzgerald
President, CommunityHLTH
Arthur Bretonnet Global Digital Innovation LeadUCB Pharma
Arthur Bretonnet
Global Digital Innovation LeadUCB Pharma
Chris Wasden Chief Strategy OfficerTwill
Chris Wasden
Chief Strategy OfficerTwill
Emma Carr Co-Founder and Chief Scientific OfficerAmara Therapeutics
Emma Carr
Co-Founder and Chief Scientific OfficerAmara Therapeutics
Jeff Wandzura CEOKEEP Labs
Jeff Wandzura
CEOKEEP Labs
Jock Thompson CEOHyduro, Inc.
Jock Thompson
CEOHyduro, Inc.
Maxime Champain Search & Evaluation lead, External InnovationBiogen
Maxime Champain
Search & Evaluation lead, External InnovationBiogen
Patrick Keenan Digital Health Program Lead - DIGITIVAAstellas Rx+
Patrick Keenan
Digital Health Program Lead - DIGITIVAAstellas Rx+
Piotr Sokolowski Chief Medtech StrategistS3 Connected Health
Piotr Sokolowski
Chief Medtech StrategistS3 Connected Health

About this Meeting

In the last few years, we have seen significant growth in the DTx market in the US. DTx companies have tested many different business models, from partnerships with pharma and medtech, to agreements with payers or employers, and D2C models. However, the market is now more crowded than ever and the economic situation is changing, which makes it harder to nail down the most scalable and sustainable business model for DTx in the US.    

 What are the best models for DTx in the US in this new reality? How will the business models change in the future? Join us in a peer-to-peer conversation where we will discuss: 

  • What will the best business models be in the next few years for DTx companies in the US? How can companies start preparing for this?
  •  How to define your company strategy for both scalability and sustainability?  
  •  Is the prescription model the way to go? Reimbursement has consistently been the main challenge for a sustainable business model, but we have seen steps in the right direction. What are the expectations for the future?  
  •  Most companies test many different business models. What is required to be successful and clearly differentiate business models that coexist? What does the pricing strategy look like in those coexisting models? 
  •  What are the new business models we are missing? Could there be potential for DTx companies to partner with traditional retail?